You are here: Industry Insights > UK

News List

CureVac, UK Partner on Vaccines Against SARS-CoV-2 Variants contractpharma
February 07, 2021
Aims to mitigate the effects of the pandemic and help prepare against future SARS-CoV-2 outbreaks by working on multiple variant vaccines.
UK trial will evaluate safety of mixing different COVID-19 vaccines pharmatimes
February 04, 2021
A new clinical study, based in the UK, will investigate alternating COVID-19 vaccine doses with the aim of examining whether different vaccines can safely be used for two-dose regimens.
UK marks first COVID vaccine milestone with care home protection expresspharma
February 03, 2021
The UK government said that it has hit a ‘crucial milestone’ in its COVID-19 vaccination programme, with figures indicating that residents at every eligible care home with older residents across England now administered a life-saving jab.
Bayer’s Xarelto approved in the UK pharmatimes
February 02, 2021
Bayer’s oral factor Xa inhibitor Xarelto (rivaroxaban) has been approved in the UK to treat venous thromboembolism (VTE) and to prevent VTE recurrence in children.
UK Secures 40 Million Doses of Valneva COVID-19 Vaccine contractpharma
February 02, 2021
The UK Government has exercised its option to order 40 million doses of Valneva SE’s inactivated, adjuvanted COVID-19 vaccine candidate for supply in 2022.
UK will offer its genomic expertise worldwide to identify new COVID-19 variants pharmatimes
January 29, 2021
The UK will offer its genomic expertise to the international community with the aim of aiding the identification of new variants of COVID-19, the government has announced.
Cross-EU drug supply chain to be most affected post Brexit: Poll pharmaceutical-technology
January 22, 2021
The UK’s decision to opt out of the European Union (EU) has set numerous industries up for disruptions especially after the official exit in January 2020.
UK could “become the world’s foremost nation for drug security,” says FarmaTrust europeanpharmaceuticalreview
January 15, 2021
The global medical authentication provider is urging the government to secure the UK’s medicines supply by modernising the system with blockchain technologies.
Diurnal seeks marketing authorisation for Chronocort in the UK pharmatimes
January 14, 2021
UK speciality pharma Diurnal has submitted a marketing authorisation application for Chronocort (modified-release hydrocortisone) to the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for patients with the rare condition congenital ...
Healthcare sector could take more than three years to stabilise in the event of no-deal Brexit: Poll pharmaceutical-technology
January 14, 2021
Until the signing of the new trade deal in December 2020, speculation was high on the adverse impact of a no-deal Brexit on the UK healthcare.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page